| Literature DB >> 33047495 |
Lisa D Hawke1,2, Suneeta Monga3,2, Daphne Korczak3,2, Em Hayes1, Jacqueline Relihan1, Karleigh Darnay1, Kristin Cleverley2, Yona Lunsky1,2, Peter Szatmari1,2, Joanna Henderson1,2.
Abstract
AIM: To examine mental health in conjunction with physical health during the COVID-19 pandemic among youth with physical health conditions compared to those without.Entities:
Keywords: COVID-19; mental health; pandemic; physical health; substance use; youth
Mesh:
Year: 2020 PMID: 33047495 PMCID: PMC7675347 DOI: 10.1111/eip.13052
Source DB: PubMed Journal: Early Interv Psychiatry ISSN: 1751-7885 Impact factor: 2.721
Demographic characteristics by sample
| Demographic characteristic | Clinical | Nonclinical | ||
|---|---|---|---|---|
| N | % | N | % | |
| Gender | ||||
| Man/boy | 75 | 27.2 | 129 | 37.3 |
| Woman/girl | 179 | 64.9 | 210 | 60.7 |
| Another gender | 22 | 8.0 | 7 | 2.0 |
| Ethnic origin/background | ||||
| Caucasian | 173 | 63.1 | 207 | 59.8 |
| Asian (East and Southeast) | 17 | 6.2 | 48 | 13.9 |
| South Asian | 12 | 4.4 | 35 | 10.1 |
| Black (African, Caribbean, North American) | 9 | 3.3 | 19 | 5.5 |
| Indigenous | 2 | 0.7 | 5 | 1.4 |
| Multiple | 35 | 12.8 | 13 | 3.8 |
| Other background | 26 | 9.5 | 19 | 5.5 |
| Born in Canada | 239 | 86.9 | 306 | 88.4 |
| First language English | 257 | 93.5 | 308 | 89.0 |
| Student | 172 | 62.5 | 223 | 64.4 |
| Highest level of education | ||||
| Less than high school | 94 | 34.3 | 13 | 3.8 |
| High school diploma | 61 | 22.3 | 79 | 22.9 |
| Some college, university, or technical school | 82 | 29.9 | 146 | 42.3 |
| Postsecondary diploma or certification | 37 | 13.5 | 107 | 31.0 |
| Employed before COVID‐19 | 145 | 52.7 | 240 | 69.8 |
| Employed now | 56 | 20.5 | 123 | 35.8 |
Mental health, substance use, and physical health ratings of youth across the four groups of different physical health concerns, with nonparametric significance tests
| Asthma/allergies (atopic group) | |||||
|---|---|---|---|---|---|
| Yes (N = 265) | No (N = 355) |
| |||
|
| SD |
| SD | ||
| Mental health | 3.40 | 0.78 | 3.21 | 0.81 | .003 |
| Substance use | 1.54 | 0.61 | 1.47 | 0.56 | .143 |
| Physical health | 2.99 | 1.09 | 3.06 | 1.12 | .818 |
Note: Bonferroni‐corrected P values within each group are .017 to conclude significance.
Logistic regression prediction of health group membership based on mental health, substance use, and physical health, controlling for pre‐COVID‐19 status and sample
|
| SE | Wald (World Health Organization, |
| OR (95% CI) | |
|---|---|---|---|---|---|
| Asthma/allergies (atopic group) | |||||
| Mental health | 0.278 | 0.117 | 5.682 | .017 | 1.321 (1.051, 1.660) |
| Substance use | 0.320 | 0.274 | 1.358 | .244 | 1.377 (0.804, 2.358) |
| Physical health | −0.056 | 0.095 | 0.340 | .560 | 0.946 (0.785, 1.140) |
| Other preexisting physical health condition (physical health group) | |||||
| Mental health | 0.412 | 0.133 | 9.664 | .002 | 1.510 (1.165, 1.959) |
| Substance use | 0.390 | 0.308 | 1.602 | .206 | 1.477 (0.807, 2.703) |
| Physical health | 0.338 | 0.110 | 9.471 | .002 | 1.403 (1.131, 1.740) |
| Friend/family diagnosis group with COVID‐19 (diagnosis group) | |||||
| Mental health | −0.035 | 0.205 | 0.030 | .862 | 0.965 (0.646, 1.442) |
| Substance use | −0.760 | 0.433 | 3.080 | .079 | 0.468 (0.200, 1.093) |
| Physical health | −0.099 | 0.174 | 0.322 | .570 | 0.906 (0.644, 1.274) |
| Symptoms associated with COVID‐19 (symptoms group) | |||||
| Mental health | 0.389 | 0.130 | 8.929 | .003 | 1.475 (1.143, 1.904) |
| Substance use | −0.378 | 0.293 | 1.659 | .198 | 0.685 (0.386, 1.218) |
| Physical health | 0.334 | 0.106 | 9.915 | .002 | 1.397 (1.135, 1.720) |
Note: Bonferroni‐corrected P values within each group are .017 to conclude significance.
P = .0168.
Logistic regression prediction of physical health group membership based on internalizing, externalizing, and substance use disorder, controlling for sample
| Health interest group | Not in health interest group | Wald (World Health Organization, | |||||||
|---|---|---|---|---|---|---|---|---|---|
| N | % | N | % |
| SE |
| OR (95% CI) | ||
| Asthma/allergies (atopic group) | |||||||||
| Internalizing disorder | 149 | 58.4 | 171 | 49.0 | 0.391 | 0.173 | 5.089 | .024 | 1.478 (1.053, 2.075) |
| Externalizing disorder | 75 | 29.4 | 89 | 25.5 | 0.188 | 0.191 | 0.967 | .325 | 1.207 (0.830, 1.754) |
| Substance use disorder | 35 | 13.7 | 37 | 10.6 | 0.277 | 0.265 | 1.091 | .296 | 1.319 (0.785, 2.217) |
| Other preexisting physical health condition (physical health group) | |||||||||
| Internalizing disorder | 100 | 62.9 | 220 | 49.4 | 0.492 | 0.197 | 6.242 | .012 | 1.636 (1.112, 2.407) |
| Externalizing disorder | 52 | 32.7 | 112 | 25.2 | 0.289 | 0.209 | 1.918 | .166 | 1.335 (0.887, 2.011) |
| Substance use disorder | 18 | 11.3 | 54 | 12.1 | −0.258 | 0.303 | 0.722 | .396 | 0.773 (0.427, 1.400) |
| Friend, family diagnosed with COVID‐19 (diagnosis group) | |||||||||
| Internalizing disorder | 26 | 50.0 | 294 | 53.3 | −0.277 | 0.304 | 0.829 | .363 | 0.758 (0.418, 1.376) |
| Externalizing disorder | 15 | 28.8 | 149 | 27.0 | −0.034 | 0.332 | 0.011 | .918 | 0.966 (0.504, 1.854) |
| Substance use disorder | 9 | 17.3 | 63 | 11.4 | 0.325 | 0.413 | 0.622 | .430 | 1.385 (0.617, 3.110) |
| Symptoms associated with COVID‐19 (symptoms group) | |||||||||
| Internalizing disorder | 117 | 67.6 | 203 | 47.1 | 0.730 | 0.196 | 13.906 | <.001 | 2.076 (1.414, 3.048) |
| Externalizing disorder | 65 | 37.6 | 99 | 23.0 | 0.559 | 0.202 | 7.697 | .006 | 1.750 (1.178, 2.598) |
| Substance use disorder | 29 | 16.7 | 43 | 10.0 | 0.321 | 0.273 | 1.379 | .240 | 1.379 (0.807, 2.356) |
Note: Bonferroni‐corrected P values within each group are .017 to conclude significance.